Background
The second wave of COVID-19 pandemic has seen an unprecedented rise in the number of mucormycosis cases worldwide and in India particularly. This otherwise rare fungal infection has become an endemic among patients who have recovered from recent SARS-CoV-2 infection. Among the different types of mucormycosis, rhino-orbital-cerebral involvement has mainly been observed in the recent surge of cases. Very few cases of mucormycosis of mandible have been reported in literature and none in COVID-19 patients. We report a case of isolated mandibular mucormycosis in a COVID- 19 patient, with no other predisposing comorbidities.
Case report
A 39 year old patient recently recovered from COVID-19 presented with typical symptoms of osteomyelitis which was confirmed using computed tomography of face. He underwent thorough debridement and curettage and tissue was sent for culture, special staining and biopsy.
Result
Diagnosis of mucormycosis was confirmed based on postoperative biopsy and special staining. He was further managed with complete course of appropriate antifungal therapy.
Conclusion
Mucormycosis is a fulminant and aggressive infection which requires prompt diagnosis and intervention. Early referral to a maxillofacial surgeon by physicians and general dental practitioners on seeing signs and symptoms of secondary fungal infections involving maxilla or mandible in patients with history of SARS-CoV-19 infection can improve prognosis.
a b s t r a c tThe increasing awareness of the depletion of fossil fuel resources and the environmental benefits motivates the use of vegetable oils, however there is little known information about ignition and combustion characteristics of vegetable oil based fuels under off diesel engine conditions. These conditions are normally reached either during starting or when the engine is sufficiently worn out. A fuel was prepared by co-solvent blending of coconut oil with 20% butyl alcohol and was analysed. An experimental study of the measurement of ignition delay (ID) characteristics of conical fuel sprays impinging on hot surface in cylindrical combustion chamber was carried out. The objective of the study was to investigate the effect of hot surface temperatures on ignition delays of microemulsion of coconut oil at various ambient air pressures and temperatures which would have reached under off diesel engine conditions. An experimental set-up was designed and developed for a maximum air pressure of 200 bar and a maximum temperature of 800 C with the emphasis on optical method for the measurement of ignition delay. Hot surface temperature range chosen was 300e450 C and ambient air pressure (inside the combustion chamber) range chosen was 10e25 bar. Present study shows that at fixed injection pressure and fixed ambient (hot surface) temperature, at higher ambient air pressure (25 bar) inside the combustion chamber, ignition delay of diesel and microemulsion of coconut oil are comparable and therefore are having matching combustion characteristics. Although a pressure of 25 bar is much less than the precombustion pressure of most diesel engines but again conclusively establish that combustion characteristics are same despite lower air pressure, temperature and lower injection pressure. At higher injection pressure ignition delay of microemulsion of coconut oil and pure diesel attains the lower value at the same ambient air pressure inside the combustion chamber. It can also be seen that at fixed injection pressure and higher ambient temperature conditions, ignition delay variations of microemulsion of coconut oil with chamber pressure show approximate same trend as that of conventional diesel fuel.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.